Clinical Trial Update: Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Pfizer completed a Phase 2 trial evaluating the safety and efficacy of PF-04991532 in adults with Type 2 diabetes mellitus. Results were posted on 2013-08-06.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PF-04991532 (PF-04991532)

Snippet

Sponsor: Pfizer | Conditions: Diabetes, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2013-08-06